Rainer Kaiser/LInkedIn
Jul 12, 2026, 20:21
Rainer Kaiser: How T Cells Boost Myeloid Effector Functions in Endocarditis
Rainer Kaiser, Internal Medicine and Cardiology Specialist at LMU Klinikum München, shared a post on LinkedIn:
“For an exciting update on our most recent take on translational immunothrombosis research, come and join us for the session ‘Bacterial impact on immunothrombosis’ to learn how T cells boost myeloid effector functions in endocarditis.
- Monday, July 13th
- 10:15 am (session starts at 09:30 am)
- Room W05-06
See you in Paris!”
Stay Updated with the Latest ISTH 2026 Updates on Hemostasis Today.
-
Aug 29, 2026, 17:05What If Factor XI inhibition Could Reshape the Future of Anticoagulation – ISTH
-
Aug 29, 2026, 16:44Nipocalimab for Warm Autoimmune Hemolytic Anemia: What the FDA Approval Means
-
Aug 29, 2026, 16:17The Future of Bleeding Disorder Research is Getting Bigger – Global Hemophilia Report
-
Aug 29, 2026, 16:03Marco De Giovanni: The Platelet – Serotonin Link Behind Severe COVID-19
-
Aug 29, 2026, 16:01FDA Approves Imaavy for wAIHA – Thalassaemia International Federation
-
Aug 29, 2026, 16:00Dianne E. van der Wal: Advancing Platelet Research at ISTH 2026 in Paris
-
Aug 29, 2026, 15:55Cory Dugan: Iron Deficiency and Anemia Across the Female Life
-
Aug 29, 2026, 15:53Melina Rodriguez: FDA Approves Imaavy as First Treatment for Warm AIHA
-
Aug 29, 2026, 15:50Karen T․: Seeking a Patient Liaison to Support the Bleeding Disorders Community